SREI Infrastructure Finance Ltd:企業のM&A・事業提携・投資動向

◆英語タイトル:SREI Infrastructure Finance Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
◆商品コード:DATA904C1412
◆発行会社(調査会社):MarketLine
◆発行日:2018年7月
◆ページ数:70
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:インド
◆産業分野:サービス
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD700 ⇒換算¥103,600見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD1,050 ⇒換算¥155,400見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

SREI Infrastructure Finance Ltd – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
Summary

Marketline’s SREI Infrastructure Finance Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by SREI Infrastructure Finance Ltd since January2007.

Synopsis

Marketline’s Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage.

Key Highlights

This report includes SREI Infrastructure Finance Ltd’s contact information and business summary, tables, graphs, a list of partners and targets, a breakdown of financial and legal advisors, deal types, top deals by deal value, detailed deal reports, and descriptions and contact details of the partner, target, investor, and vendor firms, where disclosed.

The profile also includes detailed deal reports for all M&A, private equity, public offering, venture financing, partnership and divestment transactions undertaken by SREI Infrastructure Finance Ltd. These deal reports contain information about target company financials, sources of financing, method of payment, deal values, and advisors for various parties, where disclosed.

Scope

- Provides intelligence on SREI Infrastructure Finance Ltd’s M&A, strategic partnerships and alliances, capital raising and private equity transactions.
- Detailed reports of various financial transactions undertaken by SREI Infrastructure Finance Ltd and its subsidiaries since 2007.
- Information about key financial and legal advisors for SREI Infrastructure Finance Ltd’s financial deals transactions.
- Financial deals tables and charts covering deal value and volumes trend, deal types and geography-based deal activity.

Reasons to buy

- Access comprehensive financial deals data along with charts and graph covering M&A, private equity, and partnerships and alliances.
- Form an independent opinion about SREI Infrastructure Finance Ltd’s growth strategies through the organic and inorganic activities undertaken since 2007.
- Track your competitors’ business structure and growth strategies.

【レポートの目次】

Table of Contents
COMPANY OVERVIEW AND KEY FACTS 2
TABLE OF CONTENTS 5
LIST OF TABLES 7
LIST OF FIGURES 7
TARGETS AND PARTNERS 8
MERGERS & ACQUISITIONS 9
Mergers and Acquisitions – Overview 9
Mergers and Acquisitions – Deal reports 10
PARTNERSHIP 29
Partnership – Deal reports 29
CAPITAL RAISING 31
Capital Raising – Overview 31
Capital Raising – Deal reports 32
DIVESTMENTS 39
Divestments – Overview 39
Divestments – Deal reports 40
PRIVATE EQUITY & OWNERSHIP 54
Private Equity and Ownership – Overview 54
Private Equity and Ownership – Deal reports 55
APPENDIX 60
Contact Us 60
About MarketLine Financial Deals Database 60
Deal Definition and Methodology 62
About MarketLine 69

List of Tables
Table 1: SREI Infrastructure Finance Limited M&A volume and value trend (2014-YTD2018)
Table 2: SREI Infrastructure Finance Limited M&A activity by geography (2014-YTD2018)
Table 3: SREI Infrastructure Finance Limited capital raising volume and value trend (2014-YTD2018)
Table 4: SREI Infrastructure Finance Limited capital raising by deal type (2014-YTD2018)
Table 5: SREI Infrastructure Finance Limited divestments volume and value trend (2014-YTD2018)
Table 6: SREI Infrastructure Finance Limited divestments activity by geography (2014-YTD2018)
Table 7: SREI Infrastructure Finance Limited private equity and ownership volume and value trend (2014-YTD2018)
Table 8: SREI Infrastructure Finance Limited private equity and ownership activity by deal type (2014-YTD2018)

List of Figures
Figure 1: SREI Infrastructure Finance Limited M&A volume and value trend (2014-YTD2018)
Figure 2: SREI Infrastructure Finance Limited M&A activity by geography (2014-YTD2018)
Figure 3: SREI Infrastructure Finance Limited capital raising volume and value trend (2014-YTD2018)
Figure 4: SREI Infrastructure Finance Limited capital raising by deal type (2014-YTD2018)
Figure 5: SREI Infrastructure Finance Limited divestments volume and value trend (2014-YTD2018)
Figure 6: SREI Infrastructure Finance Limited divestments by geography (2014-YTD2018)
Figure 7: SREI Infrastructure Finance Limited private equity and ownership volume and value trend (2014-YTD2018)
Figure 8: SREI Infrastructure Finance Limited private equity and ownership by deal type (2014-YTD2018)

★海外企業調査レポート[SREI Infrastructure Finance Ltd:企業のM&A・事業提携・投資動向]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Hikma Pharmaceuticals Plc (HIK):製薬・医療:M&Aディール及び事業提携情報
    Summary Hikma Pharmaceuticals Plc (Hikma) develops, manufactures and markets branded and non-branded generics and in-licensed products. The company specializes in the therapeutic areas of cardiovascular, diabetes, central nervous system (CNS), cancer, dermatology, genitourinary system, hormones and …
  • Enterome Bioscience SA-医療機器分野:企業M&A・提携分析
    Summary Enterome Bioscience SA (Enterome) is a drug development company that develops medical tests, and companion diagnostics to develop the management of microbiome-related diseases. The company develops medical tests based on its metagenotype technology platform that helps to identify microbiome- …
  • Salem Media Group, Inc. (SALM):企業の財務・戦略的SWOT分析
    Salem Media Group, Inc. (SALM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Garmin Ltd:企業の戦略・SWOT・財務情報
    Garmin Ltd - Strategy, SWOT and Corporate Finance Report Summary Garmin Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Vedanta Resources Plc:企業の戦略・SWOT・財務分析
    Vedanta Resources Plc - Strategy, SWOT and Corporate Finance Report Summary Vedanta Resources Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Cerenis Therapeutics Holding SA (CEREN):企業の財務・戦略的SWOT分析
    Summary Cerenis Therapeutics Holding SA (Cerenis) is a biopharmaceutical company that discovers and develops HDL therapies for the treatment of cardiovascular and metabolic diseases. The company develops a portfolio of HDL therapies including HDL mimetics for the rapid regression of atherosclerotic …
  • Presidio Pharmaceuticals Inc-製薬・医療分野:企業M&A・提携分析
    Summary Presidio Pharmaceuticals Inc (Presidio) is a clinical-stage pharmaceutical company that discovers and develops small-molecule antiviral therapeutics. The company’s products include HCV NS5A, NS5B proteins, lead pan-genotypic HCV NS5A inhibitor, ravidasvir hydrochloride, protease inhibitor, f …
  • Geron Corp (GERN):医療機器:M&Aディール及び事業提携情報
    Summary Geron Corp (Geron) is a clinical stage biopharmaceutical company, which develops a telomerase inhibitor as a potential treatment for cancer. The company is evaluating its flagship product candidate Imetelstat in two clinical trials: IMbark and IMerge in partnership with Janssen Biotech, Inc. …
  • CEPS A.S.:企業の戦略的SWOT分析
    CEPS A.S. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. Th …
  • Immuron Ltd (IMC)-製薬・医療分野:企業M&A・提携分析
    Summary Immuron Ltd (Immuron), formerly Anadis Limited is a biopharmaceutical company that conducts research and develops polyclonal antibody products for humans. The company develops and produces an orally stable therapeutic for various immune mediated and inflammatory disorders. Immuron’s products …
  • Global Orthopaedic Technology Pty Ltd-医療機器分野:企業M&A・提携分析
    Summary Global Orthopaedic Technology Pty Ltd (Global) is an orthopaedic implant designer and manufacturer. The company offers orthopaedic implants for knee, hip and spine. Its hip products include global cup, bioball system, paragon stem, absolut cemented stem, and unisyn hip system among others. I …
  • JALUX Inc:企業の戦略・SWOT・財務情報
    JALUX Inc - Strategy, SWOT and Corporate Finance Report Summary JALUX Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • Keihan Holdings Co Ltd:企業の戦略・SWOT・財務分析
    Keihan Holdings Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Keihan Holdings Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • TechnoPhage SA-製薬・医療分野:企業M&A・提携分析
    Summary TechnoPhage SA (TechnoPhage) is a biotechnology company that concentrates on research and development of new molecules. The company conducts research and development of new products based on unique properties of bacteriophages. It also conducts contract research and development services for …
  • Northern Ireland Electricity Networks Ltd:企業の戦略的SWOT分析
    Northern Ireland Electricity Networks Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and …
  • Aeglea BioTherapeutics Inc (AGLE):企業の財務・戦略的SWOT分析
    Summary Aeglea BioTherapeutics Inc (Aeglea), formerly Aeglea BioTherapeutics Holdings, LLC is a biotechnology company. The company develops and commercializes human enzymes for the treatment of cancer and rare genetic diseases. The company’s lead product pipeline includes pegzilarginase (AEB1102), i …
  • Erbud SA:企業の戦略・SWOT・財務情報
    Erbud SA - Strategy, SWOT and Corporate Finance Report Summary Erbud SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …
  • Mylan NV (MYL)-製薬・医療分野:企業M&A・提携分析
    Summary Mylan NV (Mylan) is a pharmaceutical company, which develops, licenses, manufactures, markets and distributes generics and branded medicines and consumer healthcare products. It offers pharmaceutical products in multiple forms across therapeutic categories such as respiratory and allergy, ca …
  • Provogue (India) Limited (PROVOGE):企業の財務・戦略的SWOT分析
    Provogue (India) Limited (PROVOGE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Zarubezhneft:石油・ガス:M&Aディール及び事業提携情報
    Summary Zarubezhneft is an oil and gas company that explores and develops oil and gas properties. The company constructs, operates and designs oil refineries, tank farms and pipeline systems for storage, transportation and marketing operations. Its services include engineering, design and account ev …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆